Radcliffe Capital Management’s Healthcare AI Acquisition Corp. Warrants HAIAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-250,000
Closed -$14.4K 300
2023
Q3
$14.4K Hold
250,000
﹤0.01% 300
2023
Q2
$17.7K Hold
250,000
﹤0.01% 352
2023
Q1
$33.8K Hold
250,000
﹤0.01% 354
2022
Q4
$2.57M Hold
250,000
0.08% 393
2022
Q3
$2.52M Hold
250,000
0.06% 540
2022
Q2
$2.48M Hold
250,000
0.06% 572
2022
Q1
$2.48M Buy
+250,000
New +$75.4K 0.06% 549

Other funds holding HAIAW

Radcliffe Capital Management's HAIAW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of Healthcare AI Acquisition Corp. Warrants (HAIAW) in Q4 2023, closing a stake of 250,000 shares — an estimated $14.4K sold.

Radcliffe Capital Management first reported a position in HAIAW in Q1 2022 and held it in 7 quarters. The position peaked at $2.57M in Q4 2022. 35 funds tracked by Wall St. Rank hold HAIAW as of Q4 2023.

  • Radcliffe Capital Management reported no remaining Healthcare AI Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 250,000 Healthcare AI Acquisition Corp. Warrants shares in Q4 2023, an estimated $14.4K.
  • Radcliffe Capital Management first reported a position in Healthcare AI Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
  • Radcliffe Capital Management's Healthcare AI Acquisition Corp. Warrants position peaked at $2.57M in Q4 2022.
  • 35 funds tracked by Wall St. Rank held Healthcare AI Acquisition Corp. Warrants as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.